|
Apr 5
|
Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics
|
|
Apr 4
|
Madrigal Pharmaceuticals Inc Director James Daly Sells 32,489 Shares
|
|
Apr 4
|
Madrigal Pharmaceuticals Inc Director Richard Levy Sells 11,000 Shares
|
|
Apr 4
|
Madrigal Pharmaceuticals Inc Director Kenneth Bate Sells 32,489 Shares
|
|
Apr 3
|
1 No-Brainer Growth Stock to Buy Now
|
|
Apr 2
|
The 3 Best Biotech Stocks to Buy in April 2024
|
|
Mar 29
|
Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals
|
|
Mar 29
|
Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?
|
|
Mar 26
|
Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock
|
|
Mar 22
|
This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy?
|
|
Mar 19
|
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
|
|
Mar 19
|
Madrigal Pharmaceuticals Announces Pricing of Upsized $600 Million Public Offering
|
|
Mar 18
|
Madrigal Pharmaceuticals Announces Proposed Public Offering
|
|
Mar 18
|
Madrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark
|
|
Mar 18
|
Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That
|
|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
|
Mar 17
|
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
|
|
Mar 15
|
Wegovy and Zepbound Cast Shadow Over Madrigal’s Liver Drug
|
|
Mar 15
|
Geron, Madrigal Pharmaceuticals jump on good news from FDA
|
|
Mar 15
|
Madrigal Pharmaceuticals Stock Surges After FDA Approves Liver Disease Treatment
|